HitIQ Accelerates Global Rollout of PROTEQT With North American Push, Retail Expansion and New Partnerships

An announcement from HitIQ Limited ( (AU:HIQ) ) is now available.

HitIQ reported a pivotal December quarter as it accelerates from technology validation to commercial rollout of its PROTEQT concussion monitoring platform, securing an exclusive Canadian distribution deal that opens the North American collision-sports market and provides a pathway into the US. Domestically, the company began national retail distribution with Rebel, expanding access to community athletes and boosting brand visibility, while its selection in an Australian Research Council-funded brain injury program and new US collegiate research with Smith College Women’s Rugby further strengthen its evidence base and appeal to regulators and medical stakeholders. HitIQ also broadened its business model through a world-first partnership with insurer Sportscover to embed PROTEQT into sports insurance offerings, initially with Hockey Australia, and reinforced its balance sheet with an oversubscribed $925,000 capital raise and shareholder approval at its AGM, supporting ongoing product development and commercial execution.

The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.

More about HitIQ Limited

HitIQ Limited is an Australian sports technology company focused on concussion monitoring and brain injury detection in collision and contact sports. Its core product, the PROTEQT system, targets elite, institutional and grassroots sporting markets globally, with a growing focus on North America and consumer retail channels through partnerships with major sporting retailers, research institutions and insurance providers.

Average Trading Volume: 836,046

Technical Sentiment Signal: Sell

Current Market Cap: A$9.03M

For a thorough assessment of HIQ stock, go to TipRanks’ Stock Analysis page.